Nanoviricides (NNVC) Intangibles (2011 - 2026)
Nanoviricides (NNVC) posted Intangibles of $310836.0 for Q1 2026, down 32.27% sequentially from $458954.0 in Q4 2025, and down 2.59% YoY from $319106.0 in Q1 2025.
Nanoviricides (NNVC) Intangibles (2011 - 2026) Analysis & Trends
Nanoviricides has reported Intangibles for 16 years, with the latest figure at $310836.0 in Q1 2026.
- Quarterly Intangibles fell 2.59% year-over-year to $310836.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $310836.0 (down 2.59% YoY) and the FY2025 annual result came in at $11478.0, down 97.5% from the prior year.
- Intangibles slipped to $310836.0 in Q1 2026 per NNVC's latest filing, from $458954.0 in the prior quarter.
- Over five years, Intangibles peaked at $458954.0 in Q3 2022 and troughed at $9410.0 in Q3 2025.
- A 5-year average of $314890.5 and a median of $331511.0 in 2023 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 42.9% in 2025, down 97.5% in 2025.
- Over 5 years, Intangibles stood at $337713.0 in 2022, then dropped by 2.45% to $329443.0 in 2023, then decreased by 2.51% to $321174.0 in 2024, then jumped by 42.9% to $458954.0 in 2025, then sank by 32.27% to $310836.0 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $310836.0, $458954.0, and $9410.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Nanoviricides | 29.50 Mn | 26.28 Mn | - | 458,954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,836.00 |
| Dec 31, 2025 | 458,954.00 |
| Sep 30, 2025 | 9,410.00 |
| Jun 30, 2025 | 11,478.00 |
| Mar 31, 2025 | 319,106.00 |
| Dec 31, 2024 | 321,174.00 |
| Sep 30, 2024 | 323,241.00 |
| Jun 30, 2024 | 458,954.00 |
| Mar 31, 2024 | 327,376.00 |
| Dec 31, 2023 | 329,443.00 |
| Sep 30, 2023 | 331,511.00 |
| Jun 30, 2023 | 333,578.00 |
| Mar 31, 2023 | 335,646.00 |
| Dec 31, 2022 | 337,713.00 |
| Sep 30, 2022 | 458,954.00 |
| Jun 30, 2022 | 341,848.00 |
| Mar 31, 2022 | 343,916.00 |
| Dec 31, 2021 | 458,954.00 |
| Sep 30, 2021 | 458,954.00 |
| Jun 30, 2021 | 458,954.00 |